Imaging of Tau Pathology in Neurodegenerative Diseases: An Update
Open Access
- 1 May 2021
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 51 (3) , 253-263
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseNew England Journal of Medicine, 2014
- [11C]PBB3—a new PET ligand that identifies tau pathology in the brains of patients with ADNature Reviews Neurology, 2013
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer DiseaseJournal of Nuclear Medicine, 2013
- Epidemiology of early-onset dementia: a review of the literatureClinical Practice & Epidemiology in Mental Health, 2013
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's diseaseBrain, 2011
- Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD PatientsJournal of Nuclear Medicine, 2011
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.Proceedings of the National Academy of Sciences, 1986
- Predicted Folding of β‐Structure in Myelin Basic ProteinJournal of Neurochemistry, 1984